In detail, miR‐200b‐3p from MSCs‐EVs could relieve MI via reducing oxidative stress and repairing cardiac function through downregulating BCL2L11 and inactivating NLRP1 (Figure 8). The gene discussed is BCL2L11; the disease is myocardial infarction.